Abstract
To improve the efficacy and tolerance of the 5-fluorouracil (5-FU)/cisplatin combination in metastatic esophageal cancer, we designed a new therapeutic schedule, the HLFP regimen. 42 patients with metastatic oesophageal adenocarcinoma (n=10) or squamous cell carcinoma (n=32) were prospectively enrolled in the study. All had bidimensionally measurable disease. The HLFP regimen consisted of twice-monthly oral administration of hydroxyurea 1 g/m(2) on days 0, 1 and 2; a 2-h infusion of leucovorin 200 mg/m(2) and a bolus of 5-FU 400 mg/m(2) followed by a 22-h infusion of 5-FU 600 mg/m(2) on days 1 and 2; and, every two cycles, 80 mg/m(2) cisplatin on day 3. Relief of dysphagia and other symptoms were monitored, together with body weight changes. Major objective responses were observed in 24 patients (57%, 95% Confidence Interval (CI): 42-72%), including four complete responses (10%). The median progression-free survival and overall survival times were 8 and 12.7 months, respectively. Weight gain was observed in 48% of patients, and dysphagia improved in 76%. Grade 3-4 toxicity occurred in 40% of patients, with grade 4 neutropenia in 12% and grade 3 thrombocytopenia, vomiting and diarrhoea in 7-9% of patients. There were no treatmen...Continue Reading
References
Jun 11, 1992·The New England Journal of Medicine·A HerskovicB Emami
Jan 1, 1981·Cancer·A B MillerA Winkler
Oct 28, 1993·The New England Journal of Medicine·K KnyrimN Vakil
Nov 1, 1994·Endoscopy·H J DittlerG R Siewert
Nov 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P G JohnstonC J Allegra
Feb 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A de GramontM Krulik
Jul 17, 1997·The New England Journal of Medicine·J F BossetT Sahmoud
Apr 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E RaymondM Krulik
Jul 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H BleibergT Sahmoud
May 5, 1999·Acta Oncologica·E WarnerA Hrincu
May 9, 2000·Journal of the American College of Surgeons·J M DalyA M Fremgen
Aug 22, 2000·Cancer·C KosmasM J Antonopoulos
Oct 24, 2000·Cancer·J FeliuM González Barón
May 28, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A M MauerE E Vokes
Oct 7, 2006·Current Opinion in Gastroenterology·J J Van LanschotP J Bakker
Citations
Jul 10, 2008·Breast Cancer Research : BCR·Joanna LisztwanDean B Evans
Nov 26, 2013·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Yann TouchefeuEmmanuel Mitry
Nov 30, 2012·Acta Oncologica·Cecilie Delphin AmdalKristin Bjordal
Sep 14, 2010·Medical Hypotheses·Peter Kovacic
Aug 12, 2004·Cancer·Geoff DelaneySusannah Jacob
Aug 8, 2014·Anti-cancer Drugs·Carol O'CallaghanOrla P Barry
Dec 14, 2011·Expert Review of Anticancer Therapy·Kapish MadaanTarawanti Verma